Syndax Pharmaceuticals Inc Quarterly Common Stock, Shares, Issued from Q4 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Syndax Pharmaceuticals Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2017 to Q2 2024.
  • Syndax Pharmaceuticals Inc Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 85M shares, a 22.5% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 85M +15.6M +22.5% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 85M +16.5M +24.1% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 84.8M +16.7M +24.5% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 69.6M +9.52M +15.8% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 69.4M +13M +23.1% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 68.5M +13.5M +24.5% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 68.1M +13.1M +23.9% Dec 31, 2022 10-Q 2023-11-02
Q3 2022 60.1M +11.3M +23.1% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 56.4M +7.78M +16% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 55M +6.78M +14.1% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 55M +7.1M +14.8% Dec 31, 2021 10-Q 2022-11-03
Q3 2021 48.9M +10M +25.8% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 48.6M +10.1M +26.2% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 48.2M +18M +59.5% Mar 31, 2021 10-Q 2021-05-11
Q4 2020 47.9M +20.7M +76.4% Dec 31, 2020 10-Q 2021-11-15
Q3 2020 38.8M +11.7M +43.1% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 38.5M +11.4M +42% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 30.2M +3.15M +11.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 27.1M +2.3M +9.28% Dec 31, 2019 10-Q 2020-11-05
Q3 2019 27.1M +3.09M +12.8% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 27.1M +4.41M +19.4% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 27.1M Mar 31, 2019 10-Q 2019-05-08
Q4 2018 24.8M +446K +1.83% Dec 31, 2018 10-Q 2019-11-07
Q3 2018 24.1M Sep 30, 2018 10-Q 2018-11-05
Q2 2018 22.7M Jun 30, 2018 10-Q 2018-08-08
Q4 2017 24.4M Dec 31, 2017 10-Q 2018-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.